Gaxos.AI Reports Revenue Surge to $1.81 Million, Net Loss Increases to $2.47 Million

Gaxos.AI Inc. reported significant financial growth in its latest quarterly filing, with revenues reaching $1.81 million for the three months ended March 31, 2026, a substantial increase from $23,732 during the same period in 2025. This growth was primarily driven by the company's RNK Health subsidiary, which generated $1.25 million from non-clinical administrative services. The company also saw revenue from subscription services rise to $563,458, compared to just $51 in the previous year. Despite this revenue surge, Gaxos.AI recorded a net loss of $2.47 million, up from a loss of $1.23 million in the prior year, reflecting increased operational costs associated with its growth strategy.

Operating expenses for Gaxos.AI surged to $4.36 million, a 207.8% increase from $1.42 million in the previous year. This rise was attributed to higher research and development costs, which doubled to $446,422, and a significant increase in advertising and marketing expenses, which soared to $2.77 million from $217,883. The company is investing heavily in its product development and marketing efforts, particularly in its Gaxos Labs and Gaxos Health initiatives, which are aimed at leveraging artificial intelligence across various sectors.

In terms of operational metrics, Gaxos.AI's total assets increased to $15.82 million as of March 31, 2026, compared to $13.42 million at the end of 2025. The company’s cash position improved to $1.51 million, alongside short-term investments of $10.20 million. The total stockholders' equity also rose to $15.25 million, reflecting the issuance of 3.1 million shares for net proceeds of approximately $5.3 million under an At The Market (ATM) offering agreement. The company’s employee headcount and user engagement metrics are expected to grow as it continues to expand its product offerings and market reach.

Looking ahead, Gaxos.AI anticipates ongoing operating losses as it implements its growth strategy, which includes further investments in research and development and marketing. The company believes its current cash and working capital will be sufficient to meet its operational needs for the next twelve months. Gaxos.AI is focused on enhancing its product portfolio, particularly in AI-driven health solutions and gaming applications, and aims to achieve a critical mass of users to drive future revenue growth. The company remains committed to its long-term vision of redefining user experiences through innovative AI applications across various industries.